Skip to main content
. 2023 Sep 28;7(24):7516–7524. doi: 10.1182/bloodadvances.2023011235

Table 2.

Bleeding and thrombosis events

Thrombocytopenia n = 274 Control n = 796
Total bleeding events, n 65 132
 Median platelet count, × 103/μL 130 234
 Bleeding type, n (%)
 Major 36 (55.4) 45 (34.1)
 Fatal 1 (1.5) 3 (2.3)
 Bleeding into critical area 6 (9.2) 8 (6.1)
 Overt bleeding 28 (43.1) 31 (23.5)
 CRNMB 29 (44.6) 87 (65.9)
 Location of bleed, n (%)
 Mucocutaneous 17 (26.2) 60 (45.1)
 Gastrointestinal 21 (32.3) 45 (33.8)
 Intracranial 3 (4.6) 7 (5.3)
 Pulmonary 3 (4.6) 7 (5.3)
 Intramuscular 5 (7.7) 4 (3.0)
 Retroperitoneal 2 (3.1) 2 (1.5)
 Pericardial 2 (3.1) 1 (0.8)
 Other 12 (18.5) 6 (4.5)
Total thrombosis events, n 19 20
 Venous, n (%) 10 (52.6) 7 (35.0)
 Deep vein thrombosis 4 (21.1) 5 (25.0)
 Pulmonary embolism 2 (10.5) 0 (0.0)
 Other 4 (21.1) 2 (10.0)
 Arterial, n (%) 9 (47.4) 13 (65.0)
 Ischemic stroke 4 (21.1) 6 (30.0)
 Acute coronary syndrome 3 (15.8) 2 (10.0)
 Other 2 (10.5) 5 (25.0)

Defined by International Society on Thrombosis and Haemostasis (ISTH) as the following spaces: intracranial, intraspinal, intraocular, retroperitoneal, intra-articular or pericardial, or intramuscular with compartment syndrome.

Defined by ISTH as bleeding causing a drop in hemoglobin ≥2g/dL or leading to a transfusion of at least 2 units of red blood cells.